Case study: NCI’s Molecular Targets Platform
The Open Targets Blog
OCTOBER 31, 2023
Despite the evidence that pediatric cancers could benefit from the same drugs used to treat adult cancers, drug trials are much rarer in children than adults. To Open Targets delivers easy-to-navigate aggregated information and evidence linking therapies, genes, and diseases.
Let's personalize your content